Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
12,083 total articles
Glaukos NASDAQ:GKOS Senior Vice President and Chief Financial Officer Alex R. Thurman sold 2,511 shares on March 25, 2026, for $106.46 per share, totaling $267,321, under a Rule 10b5-1 trading plan. The transaction left Thurman with 41,967 shares held directly, including 5,230 unvested restricted stock units. On the same date he recorded acquisitio…
Dave & Buster's Entertainment Inc CEO Tarun Lal executed two purchases totaling $69,690 for the company’s common stock in September and October 2025. The transactions — 2,500 shares at $20.52 on September 18 and 1,000 shares at $18.39 on October 21 — leave Lal with 11,560 shares directly held. The stock has since fallen to $9.81, close to its 52-we…
Anaptysbio President and CEO Daniel Faga sold 16,571 shares on March 27, 2026, to meet tax withholding obligations tied to recently vested performance-based restricted stock units. The company is moving ahead with a planned April 20, 2026 spinoff of First Tracks Biotherapeutics, which raised $80 million in a private placement, and its board has app…
Director Juan Jose Chacon Quiros sold 3,575 shares of Establishment Labs Holdings Inc. (NASDAQ: ESTA) on March 25, 2026, in a transaction totaling approximately $214,768. The sale was executed under a pre-arranged Rule 10b5-1 trading plan. Separately, Establishment Labs reported fourth-quarter 2025 results that exceeded expectations, with an EPS of…
Adam Crystal, President of R&D at Tango Therapeutics (TNGX), sold 12,000 shares on March 25, 2026, realizing roughly $241,320, and simultaneously exercised options to acquire 12,000 shares at a $5.20 strike. The transactions were carried out under a Rule 10b5-1 plan adopted on October 27, 2025. Tango reported a net loss of $38.7 million in Q4 2025 …
Apogee Therapeutics CFO Jane Henderson sold 2,000 shares of the company’s common stock on March 25, 2026, for $85.00 per share, netting $170,000. The transaction was executed under a Rule 10b5-1 trading plan adopted on September 2, 2025. The move comes amid a flurry of capital-raising activity by the company and after an analyst raised its price ta…
CoreWeave CEO and President Michael N. Intrator sold 42,693 shares of Class A stock on March 25, 2026, collecting $7,202,031 in proceeds. The trades, executed under a Rule 10b5-1 plan adopted May 23, 2025, occurred at prices between $85.5971 and $88.2534. Intrator still holds 5,666,501 shares directly following the transactions. On the same day he …
Inspired Entertainment Director Michael R. Chambrello bought $69,240 worth of common stock on March 26, 2026, bringing his direct holdings to 64,568 shares. The purchases occurred while the stock traded below InvestingPro's fair value estimate; the company reported fourth-quarter 2025 results that beat revenue expectations but missed on EPS, and pr…
James H. Dahl, listed as a 10% owner of AMREP CORP (NASDAQ: AXR), bought 4,000 shares on March 26, 2026, spending $105,210 across multiple trades executed between $25.4356 and $27.164 per share. The purchases raise his direct stake to 474,398 shares while he also holds additional shares indirectly through IRAs and a trust. The stock has returned 38…
Sandeep Bharathi, president of Marvell Technology's Data Center Group, sold 44,414 shares on March 26, 2026, for about $4.42 million under a 10b5-1 plan. The transaction came as Marvell introduced the Structera S 60260 PCIe 6.0 switch, declared a quarterly dividend, and retained Buy ratings from Stifel and UBS amid its partnerships and revenue targ…
Inspired Entertainment President and CEO Pierce Brooks H. completed a series of open-market purchases March 25-27, 2026, totaling $136,633. The trades increased his direct and indirect holdings in the company amid mixed fourth-quarter results and a continued analyst Market Outperform rating with an $11.00 price target.
Protagonist Therapeutics' Chief Financial Officer, Ali Asif, sold 24,765 shares of the company's common stock on March 26, 2026, for roughly $2.58 million at $104.24 per share. On the same day he exercised options to acquire an identical number of shares across two grants. The company recently received FDA approval for its psoriasis treatment Icoty…
Protagonist Therapeutics director Harold E. Selick exercised options to buy 24,000 shares at $12.88 and sold those shares along with an additional 24,000 shares on March 26, 2026, generating proceeds of $2.52 million from the stock sale and $309,120 tied to the option exercise. The share transactions occurred with the stock trading near its 52-week…
Arturo Molina, M.D., the chief medical officer of Protagonist Therapeutics (PTGX), sold 15,000 shares of common stock on March 26, 2026, generating about $1.57 million. Molina also exercised options to acquire 15,000 shares at $8.04. The trades come as Protagonist shares have climbed sharply following FDA approval of Icotyde (icotrokinra), promptin…
Weil A Lorne, Executive Chairman of Inspired Entertainment, Inc. (NASDAQ: INSE), acquired 50,000 shares of the company’s common stock across three transactions from March 25 to March 27, 2026, totaling roughly $339,915. The purchases occurred while the shares traded near a 52-week low of $6.10 and followed a quarter in which the company missed EPS …
Sonya Morris, a director of PIMCO Municipal Income Fund II (PML), purchased 5,000 common shares on March 25, 2026, at $7.4779 per share for a total of approximately $37,389. The trade leaves Morris with direct ownership of 5,000 shares. The transaction occurred while PML shares were trading near their 52-week low of $7.10 and are quoted at $7.35. T…
Japan Post Holdings Co., Ltd. sold 14,200 shares of Aflac Inc. on March 25, 2026, generating $1,519,826 at a weighted average price of $107.03. The transaction leaves Japan Post with an indirect stake of 52,018,600 Aflac shares. Aflac reported mixed fourth-quarter 2025 results with an EPS shortfall and a revenue beat, and Mizuho adjusted its price …
Fidelma Russo, Executive Vice President and GM of Hybrid Cloud & CTO at Hewlett Packard Enterprise Co (HPE), sold 34,001 shares of HPE common stock on March 25, 2026, for a total of $852,745 under a trading plan adopted December 23, 2025. The transactions, disclosed on a Form 4 filing, occurred in two tranches at average prices of $24.21 and $25.95…
Hewlett Packard Enterprise President and CEO Antonio Neri sold 264,432 shares on March 25, 2026, in transactions totaling $6.66 million under a prearranged trading plan. The sale occurred while HPE shares traded close to a 52-week high after a 54% year-over-year gain. The company has also completed a $2 billion senior note offering and introduced s…
Indie Semiconductor President Ichiro Aoki sold 200,000 Class A shares between March 25 and March 27, 2026, for $643,185 under a Rule 10b5-1 trading plan. The transactions coincided with a roughly 25% week-over-week share price rise and follow corporate developments including a 399 nm ultraviolet laser diode announcement, a $150 million convertible …
Hewlett Packard Enterprise executive Neil B. MacDonald sold 112,652 shares of HPE common stock on March 25, 2026, in two transactions that netted roughly $2.8 million, according to a Form 4 filing with the Securities and Exchange Commission. The sale, completed under a trading plan adopted on 09/30/25, comes as HPE rolls out AI and security product…
Indie Semiconductor Chief Executive Officer Donald McClymont sold 50,000 shares of Class A common stock on March 25, 2026, for about $153,110 under a Rule 10b5-1 trading plan. The company concurrently disclosed a product milestone in ultraviolet laser diodes for quantum computing, planned convertible note offerings due 2031, and a new in-cabin moni…
Williams-Sonoma Inc's CFO Jeffrey Howie executed a sale of 31,064 shares on March 26, 2026, generating about $5.9 million at prices between $179.37 and $183.11. The transaction, filed on a Form 4, leaves Howie with 34,138 shares outstanding and was followed by a March 25 grant of 10,077 restricted stock units that vest in equal installments from 20…
Charles F. Willis IV, executive chairman of Willis Lease Finance Corp, sold 15,031 shares of company common stock between March 25 and March 27, 2026, generating roughly $2.74 million in proceeds. The transactions span prices from $168.023 to $177.567. The stock has dipped modestly over the past week, while external analysis cited in company resear…
Todd Michael Fruhbeis, a director at Star Equity Holdings (NASDAQ:STRR), acquired multiple blocks of common stock totaling $24,047 across late March 2026 and exercised restricted stock units, while the company completed a $1.7 million sale-leaseback, launched a $2 million 10b5-1 buyback plan and updated executive compensation and potential M&A inte…
